According to Zen Score, the 3 best medical distribution stocks to buy right now are:
1. Cencora (NYSE:COR)
Cencora (NYSE:COR) is the top medical distribution stock with a Zen Score of 51, which is 12 points higher than the medical distribution industry average of 39. It passed 19 out of 38 due diligence checks and has strong fundamentals. Cencora has seen its stock return 32.51% over the past year, overperforming other medical distribution stocks by 4 percentage points.
Cencora has an average 1 year
price target of $249.50, an upside of 11.09% from Cencora's current stock price of $224.60.
Cencora stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Cencora, 33.33% have issued a Strong Buy rating, 33.33% have issued a Buy, 33.33% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
2. Cardinal Health (NYSE:CAH)
Cardinal Health (NYSE:CAH) is the second best medical distribution stock with a Zen Score of 49, which is 10 points higher than the medical distribution industry average of 39. It passed 18 out of 38 due diligence checks and has strong fundamentals. Cardinal Health has seen its stock return 16.85% over the past year, underperforming other medical distribution stocks by -12 percentage points.
Cardinal Health has an average 1 year
price target of $116.57, an upside of 17.12% from Cardinal Health's current stock price of $99.53.
Cardinal Health stock has a consensus Buy recommendation according to Wall Street analysts. Of the 7 analysts covering Cardinal Health, 28.57% have issued a Strong Buy rating, 28.57% have issued a Buy, 28.57% have issued a hold, while 0% have issued a Sell rating, and 14.29% have issued a Strong Sell.
3. Zynex (NASDAQ:ZYXI)
Zynex (NASDAQ:ZYXI) is the third best medical distribution stock with a Zen Score of 49, which is 10 points higher than the medical distribution industry average of 39. It passed 20 out of 38 due diligence checks and has strong fundamentals. Zynex has seen its stock return 9.16% over the past year, underperforming other medical distribution stocks by -20 percentage points.
Zynex has an average 1 year
price target of $18.00, an upside of 71.59% from Zynex's current stock price of $10.49.
Zynex stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Zynex, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.